You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Herpes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Review of Antiviral Therapy for Herpes Labialis

Melody Vander Straten, MD; Daniel Carrasco, MD; Patricia Lee, MD; Stephen K. Tyring, MD, PhD

Arch Dermatol. 2001;137:1232-1235.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The study by McKeough and Spruance1 in this issue of the ARCHIVES demonstrates the relative efficacy of 4 topical antiviral agents for the treatment of herpes simplex virus type 1 (HSV-1) infection using the backs of guinea pigs. Efficacy was measured by reductions in lesion number, area, and virus titer. They found, in this model, that the relative efficacy of penciclovir cream was greater than acyclovir cream, acyclovir cream was greater than or equal to acyclovir ointment, and acyclovir ointment was greater than n-docosanol cream. A clinical study comparing all 4 agents would be very expensive and is unlikely ever to be done. The authors note, however, that the guinea pig model is twice as sensitive to antiviral therapies as is herpes labialis. It is therefore interesting that the relative efficacies in the animal model . . . [Full Text of this Article]

TRANSMISSION AND PATHOGENESIS

CLINICAL MANIFESTATIONS

ANTIVIRAL THERAPY

CONCLUSIONS

From the Departments of Microbiology/Immunology (Drs Vander Straten, Carrasco, Lee, and Tyring), Dermatology (Dr Tyring), and Internal Medicine (Drs Straten, Carrasco, Lee, and Tyring), University of Texas Medical Branch, Galveston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Comparison of New Topical Treatments for Herpes Labialis: Efficacy of Penciclovir Cream, Acyclovir Cream, and n-Docosanol Cream Against Experimental Cutaneous Herpes Simplex Virus Type 1 Infection
Mark B. McKeough and Spotswood L. Spruance
Arch Dermatol. 2001;137(9):1153-1158.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Review of Common Pediatric Lip Lesions: Herpes Simplex/Recurrent Herpes Labialis, Impetigo, Mucoceles, and Hemangiomas
Bentley et al.
CLIN PEDIATR 2003;42:475-482.
ABSTRACT  

High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter Studies
Spruance et al.
Antimicrob. Agents Chemother. 2003;47:1072-1080.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.